Nicardipine Hydrochloride Controlled-release Tablets(Beijing Wehand-Bio Pharma)

盐酸尼卡地平控释片(北京五和博澳药业)

Report date: 2026/03/16 20:01:47

Base Information

Drug NameNicardipine Hydrochloride Controlled-release Tablets(Beijing Wehand-Bio Pharma)
Drug Alias NameNicardipinum Hydrochloride尼卡迪平Nicardipino Hydrochloride尼龙卡地平nicardipine +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A